Meeder Asset Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15
Closed -$3K 2194
2019
Q1
$3K Buy
15
+3
+25% +$1.21K ﹤0.01% 1520
2018
Q4
$4K Buy
12
+1
+9% +$777 ﹤0.01% 1486
2018
Q3
$13K Buy
11
+5
+83% +$4.61K ﹤0.01% 1118
2018
Q2
$4.84K Buy
6
+1
+20% +$831 ﹤0.01% 1284
2018
Q1
$5K Sell
5
-7
-58% -$7.74K ﹤0.01% 1249
2017
Q4
$11K Buy
+12
New +$11.1K ﹤0.01% 1111

Other funds holding HSTO

Meeder Asset Management's HSTO Position: Q2 2019 in Review

Meeder Asset Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 15 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in HSTO in Q4 2017 and held it in 6 quarters. The position peaked at $13K in Q3 2018. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • Meeder Asset Management reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Meeder Asset Management sold 15 Histogen Inc. Common Stock shares in Q2 2019, an estimated $3K.
  • Meeder Asset Management first reported a position in Histogen Inc. Common Stock in Q4 2017 and held it in 6 quarters.
  • Meeder Asset Management's Histogen Inc. Common Stock position peaked at $13K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on Meeder Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.